LOD, Israel--(BUSINESS WIRE)--TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal ...

Eli Lilly (NYSE: LLY) has entered into a licensing and development agreement with TransPharma Medical Ltd., an Israel-based developer of trans-dermal drug delivery solutions. The deal relates to a ...

LOD, Israel--(BUSINESS WIRE)-- TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal ...

LOD, Israel--(BUSINESS WIRE)--TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal ...

Syneron Medical ($ELOS) creates cosmetic lasers and other devices to help improve people's looks, focusing on processes like body contouring, hair removal, acne and ...

TransPharma Medical, a Lod, Israel-based company developing transdermal drug delivery technology, has completed a Phase Ia trial of its ViaDerm-GLP1 agonist being developed to treat Type 2 diabetes.

Deal includes nonexclusive rights to ViaDerm delivery system. Eli Lilly inked an agreement with TransPharma Medical for exclusive, worldwide rights to its osteoporosis product. Nonexclusive access to ...

TransPharma Medical Ltd. said it will receive an up-front payment of $35 million as part of a deal with Eli Lilly & Co. to develop TransPharma's needle-free ViaDerm-PTH (1-34) for osteoporosis. Under ...

Transpharma International (part of the Walden Group) – the pharmaceutical freight and logistics specialist – has entered into a strategic agreement with Arra Group, a Polish logistics company and key ...

TransPharma Medical Ltd. has announced the successful completion of the Phase 2A trial of ViaDerm-hPTH(1-34) which is being developed for the treatment of severe osteoporosis. In June 2008, Eli Lilly ...